Erik Harris insider trades: Ultragenyx Pharmaceutical (RARE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Erik reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | RARE | ↓ Sell | 10,539 | $22.80 | $240K | Direct | Mar 3, 2026 (1d) |
| Mar 3, 2025 | RARE | ↓ Sell | 15,103 | $42.10 | $636K | Direct | Mar 4, 2025 (1d) |
| Mar 1, 2024 | RARE | ↓ Sell | 4,768 | $53.76 | $256K | Direct | Mar 5, 2024 (4d) |
| Sep 5, 2023 | RARE | ↓ Sell | 6,000 | $37.96 | $228K | Direct | Sep 6, 2023 (1d) |
| Jun 19, 2023 | RARE | ↓ Sell | 305 | $48.20 | $15K | Direct | Jun 21, 2023 (2d) |
| Mar 1, 2023 | RARE | ↓ Sell | 3,664 | $45.25 | $166K | Direct | Mar 3, 2023 (2d) |
| Jun 19, 2022 | RARE | ↓ Sell | 295 | $54.78 | $16K | Direct | Jun 22, 2022 (3d) |
| Mar 1, 2022 | RARE | ↓ Sell | 2,713 | $66.62 | $181K | Direct | Mar 3, 2022 (2d) |
| Oct 14, 2021 | RARE | ↓ Sell | 303 | $81.14 | $25K | Direct | Oct 18, 2021 (4d) |
| Jul 6, 2021 | RARE | ↓ Sell | 375 | $91.53 | $34K | Direct | Jul 8, 2021 (2d) |
| Jun 21, 2021 | RARE | ↓ Sell | 1,009 | $94.82 | $96K | Direct | Jun 23, 2021 (2d) |
| May 7, 2021 | RARE | ↓ Sell | 700 | $113.67 | $80K | Direct | May 10, 2021 (3d) |
| Apr 20, 2021 | RARE | ↓ Sell | 396 | $104.28 | $41K | Direct | Apr 21, 2021 (1d) |
| Mar 2, 2021 | RARE | ↓ Sell | 3,177 | $138.17 | $439K | Direct | Mar 3, 2021 (1d) |
| Oct 14, 2020 | RARE | ↓ Sell | 220 | $88.00 | $19K | Direct | Oct 16, 2020 (2d) |
| Jun 3, 2020 | RARE | ↓ Sell | 2,516 | $74.69 | $188K | Direct | Feb 3, 2021 (245d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RARE insiders
Open-market trades in the last 12 months
About Erik Harris's insider trades
Erik Harris is EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical (RARE). Since Jun 3, 2020, Erik has reported no open-market purchases and 16 sales worth $2.7M on SEC Form 4. In the last 12 months: 1 sale ($240K).
Their filings also include grants and awards (15 filings), shares withheld for taxes (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RARE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.